Purchase
Description
Daratumumab biosimilar is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody against CD38 antigen, produced in a mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology. The molecular weight of daratumumab is approximately 148 kDa.
Daratumumab biosimilar is supplied at a concentration of 20 mg/mL as a colorless to pale yellow preservative-free solution of pH 5.5, which contains 0.185 mg/mL glacial acetic acid, 25.5 mg/mL mannitol, 0.4 mg/mL polysorbate 20, 2.965 mg/mL sodium acetate trihydrate, 3.505 mg/mL sodium chloride.
Statement: this product is used for R&D only, not for clinical usage.
Properties
|
Name
|
Daratumumab biosimilar
|
|
CAS
NO.
|
945721-28-8
|
|
Type
|
Whole
antibody
|
|
Source
|
Human
|
|
Target
|
CD38
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
148 kDa
|
|
Formula
|
C6466H9996N1724O2010S42
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Place
of Origin
|
China (Mainland)
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508153851515151.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Daratumumab
|
